Design Therapeutics (DSGN) Operating Income: 2020
Historic Operating Income for Design Therapeutics (DSGN) over the last 1 years, with Dec 2020 value amounting to -$3.9 million.
- Design Therapeutics' Operating Income was N/A to -$3.9 million in Q4 2020 from the same period last year, while for Dec 2020 it was -$8.3 million, marking a year-over-year change of. This contributed to the annual value of -$8.3 million for FY2020, which is N/A change from last year.
- Per Design Therapeutics' latest filing, its Operating Income stood at -$3.9 million for Q4 2020, which was down 62.02% from -$2.4 million recorded in Q3 2020.
- Over the past 5 years, Design Therapeutics' Operating Income peaked at -$623,000 during Q1 2020, and registered a low of -$3.9 million during Q4 2020.
- Over the past 1 years, Design Therapeutics' median Operating Income value was -$1.9 million (recorded in 2020), while the average stood at -$2.1 million.